Sonova Holding AG stock (CH0012549785): Citi cuts price target to CHF169

Citi analyst lowered Sonova Holding AG's price target to CHF169 on May 13, 2026, amid market pressures for the Swiss hearing care leader trading near highs.

Sonova Holding AG, the Swiss-based global leader in hearing care solutions, faced analyst pressure on May 13, 2026, when Citi analyst Veronika Dubajova reduced the price target to CHF169 from a prior level, according to StreetInsider as of May 13, 2026. The stock traded at 178.20 CHF on May 12, 2026 on SIX Swiss Exchange, up 1.25% for the session, according to SIX Group as of May 12, 2026.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Sonova Holding AG
• Sector/industry: Medical devices, hearing solutions
• Headquarters/country: Switzerland
• Core markets: North America, Europe, Asia-Pacific
• Key revenue drivers: Hearing aids, cochlear implants, audiological services
• Home exchange/listing venue: SIX Swiss Exchange (SOON.SW)
• Trading currency: CHF

Sonova Holding AG: core business model

Sonova Holding AG operates as a vertically integrated provider of hearing solutions, developing, manufacturing, and distributing hearing aids and cochlear implants worldwide through brands like Phonak and Unitron. The company serves audiologists and hearing care professionals, focusing on innovative audio processing technologies including AI-driven sound enhancement.

Sonova's model emphasizes miniaturization, advanced battery life, and connectivity features that integrate with smartphones, addressing the needs of aging populations with hearing loss in developed markets such as North America and Europe.

Main revenue and product drivers for Sonova Holding AG

Revenue primarily comes from hearing instruments (around 92%), cochlear implants (about 8%), accessories, and services, as reported in company disclosures. Key products include premium hearing aids with AI features and wireless systems, driving growth in digital health solutions.

North American operations contribute significantly, providing US investors exposure to the expanding audiology market amid rising demand for hearing technologies.

Why Sonova Holding AG matters for US investors

Sonova's strong presence in North America offers US investors indirect exposure to global medtech trends in hearing care, a sector benefiting from demographic shifts like aging baby boomers. Its products are distributed through US networks, linking to healthcare spending.

Conclusion

Sonova Holding AG maintains a leading position in hearing solutions with innovation in AI and connectivity, supported by demographic tailwinds. The recent Citi price target cut to CHF169 reflects caution amid trading highs, while North American exposure ties it to US healthcare trends. Investors track upcoming results and competitive dynamics.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.